Friedreich ataxia

Archives of Neurology

Volumn 65, Issue 10, 2008, Pages 1296-1303

  Pandolfo, Massimo ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN;

ALLELE; FRIEDREICH ATAXIA; GENE MUTATION; GENE SILENCING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MOLECULAR MECHANICS; NUCLEOTIDE REPEAT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AFFERENT PATHWAYS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DISEASE PROGRESSION; FRIEDREICH ATAXIA; GAIT DISORDERS, NEUROLOGIC; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; MITOCHONDRIAL DISEASES; SPINAL CORD;

EID: 54049142098     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.10.1296     Document Type: Review

References (50)

1. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnosis criteria and intrafamilial clustering of clinical features. Brain. 1981;104(3):589-620.
2. De Michele G, Filla A, Cavalcanti F, et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry. 1994;57(8):977-979.
3. Moschner C, Perlman S, Baloh RW. Comparison of oculomotor findings in the progressive ataxia syndromes. Brain. 1994;117(pt 1):15-25.
4. Dürr A, Cossée M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich ataxia. N Engl J Med. 1996;335(16):1169-1175.
5. Koeppen A. The neuropathology of inherited ataxias. In: Manto M, Pandolfo M, eds. The Cerebellum and its Disorders. New York, NY: Cambridge University Press; 2002:387-405.
6. Friedreich N. Über degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat. 1863;26:391-419.
7. Casazza F, Morpurgo M. The varying evolution of Friedreich's ataxia cardiomyopathy. Am J Cardiol. 1996;77(10):895-898.
8. Lamarche JB, Cote M, Lemieux B. The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci. 1980;7(4):389-396.
9. Chamberlain S, Shaw J, Rowland A, et al. Mapping of mutation causing Friedreich' ataxia to human chromosome 9. Nature. 1988;334(6179):248-250.
10. Campuzano V, Montermini L, Moltó MD, et al. Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423-1427.
11. Babcock M, de Silva D, Oaks R, et al. Regulation of mitochondrial iron accumulation by Yfh1, a putative homolog of frataxin. Science. 1997;276(5319):1709-1712.
12. Cossée M, Puccio H, Gansmuller A, et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet. 2000;9(8):1219-1226.
13. Jiralerspong S, Liu Y, Montermini L, Stifani S, Pandolfo M. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol Dis. 1997;4(2):103-113.
14. Koutnikova H, Campuzano V, Foury F, Dollé P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997;16(4):345-351.
15. Musco G, Stier G, Kolmerer B, et al. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin. Structure. 2000;8(7):695-707.
16. Foury F, Pastore A, Trincal M. Acidic residues of yeast frataxin have an essential role in Fe-S cluster assembly. EMBO Rep. 2007;8(2):194-199.
17. Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet. 2004;13(23):3007-3015.
18. Yoon T, Cowan JA. Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem. 2004;279(25):25943- 25946.
19. Rötig A, deLonlay P, Chretien D, et al. Frataxin gene expansion causes aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215-217.
20. Martelli A, Wattenhofer-Donze M, Schmucker S, Bouvet S, Reutenauer L, Puccio H. Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues [published online ahead of print June 27, 2007]. Hum Mol Genet. 2007;16(22):2651-2658.
21. Condò I, Ventura N, Malisan F, Tomassini B, Testi R. A pool of extramitochondrial frataxin that promotes cell survival. J Biol Chem. 2006;281(24):16750-16756.
22. Yoon T, Cowan JA. Iron-sulfur cluster biosynthesis: characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J Am Chem Soc. 2003;125(20):6078-6084.
23. Adamec J, Rusnak F, Owen WG, et al. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet. 2000;67(3):549-562.
24. Gakh O, Park S, Liu G, et al. Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet. 2006;15(3):467-479.
25. Aloria K, Schilke B, Andrew A, Craig EA. Iron-induced oligomerization of yeast frataxin homologue Yfh1 is dispensable in vivo. EMBO Rep. 2004;5(11):1096-1101.
26. Ristow M, Pfister MF, Yee AJ, et al. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A. 2000;97(22):12239-12243.
27. Jiralerspong S, Ge B, Hudson TJ, Pandolfo M. Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett. 2001;509(1):101-105.
28. Chantrel-Groussard K, Geromel V, Puccio H, et al. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet. 2001;10(19):2061-2067.
29. Emond M, Lepage G, Vanasse M, Pandolfo M. Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology. 2000;55(11):1752-1753.
30. Schulz JB, Dehmer T, Schöls L, et al. Oxidative stress in patients with Friedreich ataxia. Neurology. 2000;55(11):1719-1721.
31. Piemonte F, Pastore A, Tozzi G, et al. Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest. 2001;31(11):1007-1011.
32. Tozzi G, Nuccetelli M, Lo Bello M, et al. Antioxidant enzymes in blood of patients with Friedreich's ataxia. Arch Dis Child. 2002;86(5):376-379.
33. Santos MM, Ohshima K, Pandolfo M. frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum Mol Genet. 2001;10(18):1935-1944.
34. Seznec H, Simon D, Bouton C, et al. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005;14(4):463-474.
35. Lodi R, Cooper JM, Bradley JL, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A. 1999;96(20):11492-11495.
36. Pianese L, Busino L, De Biase I, et al. Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. Hum Mol Genet. 2002;11(23):2989-2996.
37. Cossée M, Dürr A, Schmitt M, et al. Frataxin point mutations and clinical presentation of compound heterozygous Friedreich ataxia patients. Ann Neurol. 1999;43:200-206.
38. Pianese L, Cavalcanti F, De Michele G, et al. The effect of parental gender on the GAA dynamic mutation in the FRDA gene. Am J Hum Genet. 1997;60(2):460-463.
39. De Biase I, Rasmussen A, Endres D, et al. Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients. Ann Neurol. 2007;61(1):55-60.
40. Monticelli A, Giacchetti M, De Biase I, et al. New clues on the origin of the Friedreich ataxia expanded alleles from the analysis of new polymorphisms closely linked to the mutation. Hum Genet. 2004;114(5):458-463.
41. Sakamoto N, Chastain PD, Parniewski P, et al. Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol Cell. 1999;3(4):465-475.
42. Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature. 2003;422(6934):909-913.
43. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006;2(10):551-558.
44. Cavadini P, Gellera C, Patel PI, Isaya G. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. Hum Mol Genet. 2000;9(17):2523-2530.
45. Correia AR, Adinolfi S, Pastore A, Gomes CM. Conformational stability of human frataxin and effect of Friedreich's ataxia-related mutations on protein folding. Biochem J. 2006;398(3):605-611.
46. Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol. 1997;41(5):675-682.
47. Giacchetti M, Monticelli A, De Biase I, et al. Mitochondrial DNA haplogroups influence the Friedreich's ataxia phenotype. J Med Genet. 2004;41(4):293-295.
48. Coppola G, Choi SH, Santos MM, et al. Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration. Neurobiol Dis. 2006;22(2):302-311.
49. Sturm B, Stupphann D, Kaun C, et al. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest. 2005;35(11):711-717.
50. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 2007;6(10):878-886.